% ============================================================================
% CONSTRAINT STORY: neurotechnology_oversight
% ============================================================================
% Version: 1.0 (Deferential Realism Core + Directionality + Boltzmann + Network)
% Logic: 6.0 (Indexed Tuple P,T,E,S + Sigmoid f(d) + Coupling + Purity + Network)
% Generated: 2026-02-26
% Status: [ACTIVE]
% ============================================================================

:- module(constraint_neurotechnology_oversight, []).

:- use_module(constraint_indexing).
:- use_module(domain_priors).
:- use_module(narrative_ontology).

% --- Constraint Identity Rule (DP-001: ε-Invariance) ---
% Each constraint story must have a single, stable base extractiveness (ε).
% If changing the observable used to evaluate this constraint would change ε,
% you are looking at two distinct constraints. Write separate .pl files for
% each, link them with affects_constraint/2, and document the relationship
% in both files' narrative context sections.
%
% The context tuple is CLOSED at arity 4: (P, T, E, S).
% Do not add measurement_basis, beneficiary/victim, or any other arguments.
% Linter Rule 23 enforces context/4.
%
% See: epsilon_invariance_principle.md

% --- Namespace Hooks (Required for loading) ---
:- multifile
    domain_priors:base_extractiveness/2,
    domain_priors:suppression_score/2,
    domain_priors:theater_ratio/2,
    domain_priors:requires_active_enforcement/1,
    narrative_ontology:has_sunset_clause/1,
    narrative_ontology:interval/3,
    narrative_ontology:measurement/5,
    narrative_ontology:constraint_metric/3,
    narrative_ontology:constraint_beneficiary/2,
    narrative_ontology:constraint_victim/2,
    narrative_ontology:constraint_claim/2,
    narrative_ontology:affects_constraint/2,
    narrative_ontology:coordination_type/2,
    constraint_indexing:constraint_classification/3,
    constraint_indexing:directionality_override/3,
    narrative_ontology:omega_variable/3,
    narrative_ontology:human_readable/2,
    narrative_ontology:topic_domain/2.

/* ==========================================================================
   1. NARRATIVE CONTEXT
   ========================================================================== */

/**
 * CONSTRAINT IDENTIFICATION
 *   constraint_id: neurotechnology_oversight
 *   human_readable: Neurotechnology Oversight: Coordination and Asymmetric Power Concentration
 *   domain: biomedical_policy/technology_governance
 *
 * SUMMARY:
 *   Neurotechnology oversight represents a hybrid coordination-extraction
 *   constraint spanning clinical medicine, commercial technology development,
 *   regulatory governance, and emerging patient rights movements. The
 *   constraint exhibits simultaneous coordination function (establishing
 *   safety baselines, preventing dangerous experimentation) and asymmetric
 *   extraction (data harvesting, behavioral control through proprietary
 *   algorithms, manufacturer lock-in). Extractiveness has increased from 0.38
 *   to 0.58 over the measurement interval as technologies have advanced from
 *   basic implants to cognitive-modulating devices with continuous data
 *   collection. Theater_ratio has risen from 0.52 to 0.68, reflecting that
 *   traditional ethics review frameworks (informed consent, IRBs, Belmont
 *   principles) were designed for pharmaceutical trials and surgical
 *   procedures, not for technologies that directly modify cognition and
 *   identity. The constraint's structural function is genuine — preventing
 *   unsafe neurotechnology experimentation requires oversight. But the
 *   implementation mechanism concentrates power in technology developers and
 *   regulatory agencies while research subjects and patient-users bear
 *   extraction costs with limited exit options. Recent neurorights
 *   legislation (Chile 2021, EU proposed 2024) proposes a scaffold exit
 *   pathway: explicit rights to mental privacy, cognitive liberty, and
 *   psychological continuity would shift oversight from agency-based
 *   (regulatory approval) to rights-based (individual and collective
 *   protection).
 *
 * KEY AGENTS:
 *   - Research Subjects in Clinical Trials: Primary victims (powerless/trapped) — neurologically vulnerable, cannot exit implanted devices, subject to long-term data harvesting without lifetime visibility
 *   - Patient-Users of Therapeutic Devices: Secondary victims (moderate/constrained) — benefit from therapeutic access but locked into manufacturer ecosystems, proprietary algorithms, lifetime data extraction
 *   - Technology Developers and Device Manufacturers: Primary beneficiaries (institutional/arbitrage) — capture commercial value, market protection through regulatory approval, behavioral data assets, jurisdictional arbitrage options
 *   - Regulatory Agencies (FDA, EMA, national bodies): Institutional actors (institutional/constrained) — coordinate safety baseline but partially captured by industry expertise concentration, funding constraints, inadequate authority over post-market surveillance
 *   - Neurorights and Patient Advocacy Coalition: Organized agents (organized/mobile) — proposing scaffold exit through explicit rights legislation, building alternative governance frameworks, can operate across jurisdictions
 *   - Traditional Medical Ethics Frameworks: Institutional inertia (institutional/arbitrage) — informed consent and IRBs persist as performative ritual despite acknowledged inadequacy for neurotechnology
 *   - Analytical Observer: Civilizational perspective (analytical/analytical) — risks naturalizing contingent institutional choices (proprietary algorithms, commercial secrecy, regulatory gaps) as inherent technological limits
 */

/* ==========================================================================
   2. BASE PROPERTIES (DOMAIN PRIORS)
   ========================================================================== */

% --- Numerical metrics ---
domain_priors:base_extractiveness(neurotechnology_oversight, 0.58).
domain_priors:suppression_score(neurotechnology_oversight, 0.62).
domain_priors:theater_ratio(neurotechnology_oversight, 0.68).

% --- Constraint metric facts (engine primary keys, must mirror domain_priors) ---
narrative_ontology:constraint_metric(neurotechnology_oversight, extractiveness, 0.58).
narrative_ontology:constraint_metric(neurotechnology_oversight, suppression_requirement, 0.62).
narrative_ontology:constraint_metric(neurotechnology_oversight, theater_ratio, 0.68).

% --- Constraint claim ---
narrative_ontology:constraint_claim(neurotechnology_oversight, tangled_rope).
narrative_ontology:human_readable(neurotechnology_oversight, "Neurotechnology Oversight: Coordination and Asymmetric Power Concentration").
narrative_ontology:topic_domain(neurotechnology_oversight, "biomedical_policy/technology_governance").

domain_priors:requires_active_enforcement(neurotechnology_oversight).

% --- Structural relationships ---
narrative_ontology:constraint_beneficiary(neurotechnology_oversight, technology_developers).
narrative_ontology:constraint_beneficiary(neurotechnology_oversight, medical_institutions).
narrative_ontology:constraint_beneficiary(neurotechnology_oversight, regulatory_agencies).
narrative_ontology:constraint_victim(neurotechnology_oversight, research_subjects).
narrative_ontology:constraint_victim(neurotechnology_oversight, future_users).
narrative_ontology:constraint_victim(neurotechnology_oversight, privacy_commons).

/* ==========================================================================
   3. INDEXED CLASSIFICATIONS (P, T, E, S)
   ========================================================================== */

% PERSPECTIVE 1: RESEARCH SUBJECT (SNARE) — Trapped within informed consent frameworks that cannot capture the long-term neurological effects of implanted devices. Bears full extraction risk: data harvested for commercial development, neurological integrity exposed to experimental hardware, no exit mechanism once implanted. Cannot organize collective defense due to dispersion and neurological vulnerability.
constraint_indexing:constraint_classification(neurotechnology_oversight, snare,
    context(agent_power(powerless),
            time_horizon(biographical),
            exit_options(trapped),
            spatial_scope(global))).

% PERSPECTIVE 2: PATIENT-USERS (TANGLED ROPE) — Benefit from therapeutic access (pain relief, motor restoration, neurological treatment) but constrained by manufacturer lock-in, proprietary algorithms controlling device function, and long-term data harvesting. Genuine coordination function (medical need + device capability) alongside asymmetric extraction (behavioral data, future modifications outside user control). Exit is costly: device removal carries neurological risk, alternative treatments may be unavailable.
constraint_indexing:constraint_classification(neurotechnology_oversight, tangled_rope,
    context(agent_power(moderate),
            time_horizon(generational),
            exit_options(constrained),
            spatial_scope(national))).

% PERSPECTIVE 3: TECHNOLOGY DEVELOPERS (ROPE) — Experience the oversight framework primarily as coordination: regulatory approval processes establish market legitimacy, safety standards reduce liability exposure, and oversight infrastructure enables investor confidence. Benefits from the constraint through predictable regulatory pathways and market protection. Arbitrage capability: can relocate development to favorable jurisdictions, operate across regulatory boundaries, or transition to unregulated neurotechnology markets.
constraint_indexing:constraint_classification(neurotechnology_oversight, rope,
    context(agent_power(institutional),
            time_horizon(immediate),
            exit_options(arbitrage),
            spatial_scope(global))).

% PERSPECTIVE 4: REGULATORY AGENCIES (TANGLED ROPE) — Genuine coordination function: establish safety baselines, track adverse events, manage risk during rapid technology emergence. BUT simultaneously constrained by industry capture mechanisms: revolving door employment, technical expertise concentration in industry, inadequate funding relative to review complexity, and inability to require long-term safety data before approval. Suppressed alternatives: no binding authority over international development, cannot prevent off-label use, limited post-market surveillance power. Requires active enforcement that faces industry resistance.
constraint_indexing:constraint_classification(neurotechnology_oversight, tangled_rope,
    context(agent_power(institutional),
            time_horizon(biographical),
            exit_options(constrained),
            spatial_scope(national))).

% PERSPECTIVE 5: NEURORIGHTS ADVOCACY COALITION (SCAFFOLD) — Organized agents (patient groups, ethicists, civil liberties organizations) proposing alternatives: neurorights legislation (Chile, EU) establishing explicit rights to mental privacy, cognitive liberty, and psychological continuity. Sees oversight constraint as temporary institutional arrangement transitioning toward rights-based frameworks with sunset logic. Coalition has mobility: can operate across borders, influence policy through advocacy, build alternative governance structures. Extraction experienced as moderate because coalition agents have agency and see clear exit pathway.
constraint_indexing:constraint_classification(neurotechnology_oversight, scaffold,
    context(agent_power(organized),
            time_horizon(generational),
            exit_options(mobile),
            spatial_scope(global))).

% PERSPECTIVE 6: TRADITIONAL ETHICS FRAMEWORKS (PITON) — Institutional review boards, informed consent protocols, Belmont Report principles persist as performative theater: designed for drug trials and surgical procedures, degraded when applied to neurotechnology that directly modifies cognition and identity. Theater_ratio high: extensive ethical review documentation without capacity to address algorithmic opacity, data ownership over lifetime, or identity-continuity risks. Maintains legitimacy through procedural ritual rather than functional protection. IRB structure survives through institutional inertia despite acknowledged inadequacy for neurotechnology governance.
constraint_indexing:constraint_classification(neurotechnology_oversight, piton,
    context(agent_power(institutional),
            time_horizon(civilizational),
            exit_options(arbitrage),
            spatial_scope(global))).

% PERSPECTIVE 7: ANALYTICAL OBSERVER / NATURAL LAW VIEW (MOUNTAIN) — From civilizational/universal perspective, some technological opacity is inherent to neurotechnology: algorithmic function is intrinsically difficult to verify, long-term neurological effects require decades to observe, and the interaction between external technology and internal cognition creates irreducible measurement problems. This perspective risks naturalizing what is actually a contingent institutional arrangement (proprietary algorithms, commercial secrecy, inadequate regulatory authority) as an inherent feature of the technology itself.
constraint_indexing:constraint_classification(neurotechnology_oversight, mountain,
    context(agent_power(analytical),
            time_horizon(civilizational),
            exit_options(analytical),
            spatial_scope(universal))).

/* ==========================================================================
   4. VALIDATION TESTS
   ========================================================================== */

:- begin_tests(neurotechnology_oversight_tests).

test(perspectival_gap) :-
    constraint_indexing:constraint_classification(neurotechnology_oversight, TypePowerless, context(agent_power(powerless), _, _, _)),
    constraint_indexing:constraint_classification(neurotechnology_oversight, TypeOther, context(agent_power(moderate), _, _, _)),
    TypePowerless \= TypeOther.

test(extraction_signature) :-
    domain_priors:base_extractiveness(neurotechnology_oversight, E),
    E >= 0.46. % Ensures high-extraction Snare/Tangled territory.

test(piton_threshold) :-
    domain_priors:theater_ratio(neurotechnology_oversight, TR),
    TR >= 0.70.

:- end_tests(neurotechnology_oversight_tests).

/* ==========================================================================
   5. GENERATIVE COMMENTARY
   ========================================================================== */

/**
 * LOGIC RATIONALE:
 *   Extractiveness (0.58): Moderate-high and rising. Base extraction reflects the combination of data harvesting (behavioral, neurological, decision patterns), manufacturer lock-in (proprietary algorithms controlling device function, no user override), and career/research benefits accruing to developers during approval and early commercialization phases. The rise from 0.38 to 0.58 reflects technological transition from static implants (pacemakers) to dynamic cognitive-modulating devices (closed-loop stimulation, memory enhancement) that continuously collect and analyze neural data. Initial devices had lower extractiveness because data collection was minimal and device function was mechanical; newer devices have higher extractiveness because algorithmic opacity increases and data monetization pathways expand. Suppression (0.62): High. Significant barriers to user exit and collective resistance include: (1) irreversible neurological integration (device removal carries risk of cognitive disruption), (2) manufacturer monopoly on device maintenance and software updates, (3) information asymmetry (users unaware of data retention lifetime), (4) regulatory capture (agencies lack independent technical capacity, revolving-door employment), (5) clinical necessity (therapeutic patients cannot refuse device without losing treatment), (6) dispersal (users geographically isolated, difficult to organize). Theater_ratio (0.68): High and rising. Traditional ethics frameworks (informed consent, IRBs, Belmont principles) are substantially performative when applied to neurotechnology. They assess plausibility and risks but cannot meaningfully address: algorithmic opacity, identity continuity changes, long-term neurological effects requiring decades to observe, data ownership after device removal or death, behavioral modifications that users may not consciously perceive. The rise from 0.52 to 0.68 reflects increasing recognition among ethicists that these frameworks are inadequate — regulatory theater persists through institutional inertia despite acknowledged failure of functional protection.
 *
 * PERSPECTIVAL GAP:
 *   This constraint demonstrates sharp perspectival divergence reflecting power asymmetry and exit option differences. Technology developers (institutional/arbitrage) perceive Rope — oversight is coordination enabling market confidence and liability management. Patients with therapeutic dependence (moderate/constrained) perceive Tangled Rope — genuine need-benefit coordination mixed with extraction they cannot escape. Research subjects (powerless/trapped) perceive Snare — extraction without exit or benefit. Regulatory agencies (institutional/constrained) perceive Tangled Rope but with internal conflict — they coordinate safety but are captured by industry influence and resource constraints. The neurorights coalition (organized/mobile) perceives Scaffold — sees sunset pathway through explicit rights legislation shifting from agency-based to rights-based protection. Traditional ethics frameworks perceive themselves as coherent (Rope) but are observed as Piton — functioning as institutional theater rather than protective mechanism. The analytical observer risks Mountain (naturalizing opacity and regulatory gaps as inherent to neurotechnology) but structural data reveals this as false summit: opacity is often commercial choice (could be addressed through open-source standards), regulatory gaps are institutional failure (not technological necessity).
 *
 * DIRECTIONALITY LOGIC:
 *   Directionality derives from structural position: who benefits, who bears costs, what exit options exist. Beneficiaries (manufacturers, developers) with arbitrage options experience low d (full benefit position) → low f(d) → experience minimal or negative extraction. Constrained institutional actors (agencies) experience d ≈ 0.45 (mixed position) — they coordinate but are partially captured, producing moderate experienced extraction. Moderate victims with constrained exit (patient-users) experience d ≈ 0.60 (significant target position) → f(d) ≈ 0.95 → moderate experienced extraction. Powerless victims with trapped exit (research subjects) experience d ≈ 0.95 (full target position) → f(d) ≈ 1.42 → maximum experienced extraction. The neurorights coalition with mobile exit options experiences lower d despite victim-like structural role (d ≈ 0.55) because they have capacity to exit toward alternative governance frameworks and can credibly threaten legislative action. The analytical observer at universal scope (d ≈ 0.72) experiences neither full benefit nor full target — analytical position is symmetric with respect to the constraint.
 *
 * MANDATROPHY ANALYSIS:
 *   This constraint resolves mandatrophy by distinguishing genuine coordination function from extractive overlay. The genuine coordination function is real: oversight prevents unsafe experimentation, establishes minimum safety baselines, requires testing before human trials. This function would persist in any governance regime. The extractive overlay is equally real: proprietary algorithms, data ownership, manufacturer lock-in, regulatory capture. These are contingent institutional choices, not technical necessities. The Tangled Rope classification holds because BOTH functions are necessary to explain the constraint's structure — remove the coordination function and it would not be called 'oversight'; remove the extraction and it would reclassify as Rope. The constraint is legitimately hybrid. The mandatrophy is resolved by showing that scaffold exit (neurorights legislation) targets the extraction without eliminating coordination: explicit rights to cognitive liberty and mental privacy would reduce data harvesting and manufacturer lock-in while preserving safety oversight. This is the diagnostic signature of successful scaffold transition — functionality is preserved while extraction mechanism is dismantled. The traditional ethics framework (Piton perspective) represents mandatrophy failure: the theatrical ritual of informed consent persists but its functional purpose (meaningful risk understanding by neurologically vulnerable subjects) has atrophied.
 */

/* ==========================================================================
   6. OMEGA VARIABLES (Ω) - IRREDUCIBLE UNCERTAINTIES
   ========================================================================== */

omega_variable(
    informed_consent_neurological_limits,
    'Can informed consent frameworks meaningfully capture the risks of technologies that directly modify cognition, memory, and identity?',
    'Longitudinal analysis of adverse event reports from neural implant users; comparison of disclosed risks vs. experienced risks; documentation of identity-continuity changes attributed to device function',
    'If no: informed consent cannot legitimize extraction — consent cannot be genuine when the modification being consented to is neurological. Constraint reclassifies toward Snare. If yes but limited: partial legitimacy to consent framework; supplementary neurorights protections needed.',
    confidence_without_resolution(high)
).

narrative_ontology:omega_variable(informed_consent_neurological_limits, empirical, 'Whether informed consent can capture neurological modification risks').

omega_variable(
    algorithmic_opacity_verification_gap,
    'Is the opacity of proprietary algorithms in neural devices a technical necessity or a commercial choice that could be resolved through open-source standards?',
    'Comparative case study: closed-proprietary neural devices vs. open-source alternatives (pacemakers with published algorithms); assessment of safety trade-offs; regulatory impact if open standards were mandated',
    'If technical necessity: opacity is inherent, extraction mechanism is structural limit (mountain-adjacent). If commercial choice: opacity is extractive mechanism (regulatory capture), constraint is pure Snare from user perspective. Opens path to scaffold sunset via open standards.',
    confidence_without_resolution(medium)
).

narrative_ontology:omega_variable(algorithmic_opacity_verification_gap, empirical, 'Whether algorithmic opacity is technical necessity or commercial choice').

omega_variable(
    regulatory_capture_international_arbitrage,
    'To what extent does regulatory fragmentation across jurisdictions enable manufacturers to arbitrage toward lenient oversight, undermining global coordination function?',
    'Mapping of clinical trial locations, approval timelines, and regulatory requirements across FDA, EMA, China, India; tracking of devices approved in permissive jurisdictions but not others; analysis of manufacturer jurisdiction selection patterns',
    'High arbitrage: coordination function collapses (Rope → Snare). Low arbitrage: genuine coordination achieved despite fragmentation. Determines whether unified international standards are necessary for Tangled Rope stability.',
    confidence_without_resolution(medium)
).

narrative_ontology:omega_variable(regulatory_capture_international_arbitrage, empirical, 'Extent of regulatory arbitrage exploiting jurisdictional fragmentation').

omega_variable(
    data_ownership_lifetime_extraction,
    'Are neurotechnology users aware that behavioral/neurological data harvested during device use may be retained and analyzed indefinitely after device removal or death?',
    'Survey of user understanding of data retention policies; documentation of actual data retention practices; analysis of data monetization pathways after user death or device removal',
    'If unaware: major suppression mechanism not reflected in current base_properties.suppression value — raises effective suppression toward 0.75+. If aware but unable to control: shifts extraction mechanism from information asymmetry to coerced data harvesting. Either way, raises Snare probability.',
    confidence_without_resolution(high)
).

narrative_ontology:omega_variable(data_ownership_lifetime_extraction, empirical, 'User awareness of lifetime data extraction after device removal').

omega_variable(
    neurorights_legislative_viability,
    'Are neurorights frameworks (Chile, EU) functionally sufficient to establish enforceable protections, or do they create theater without reducing extraction?',
    'Analysis of neurorights legislation enforcement mechanisms; comparison of outcomes in jurisdictions with/without explicit neurorights laws; tracking of manufacturer compliance patterns post-legislation',
    'If sufficient: neurorights laws are genuine scaffold sunset — regulatory framework transitions toward rights-based protection with measurable extraction reduction. If theater: neurorights create performative compliance without functional change — constraint remains Snare despite legislative appearance.',
    confidence_without_resolution(medium)
).

narrative_ontology:omega_variable(neurorights_legislative_viability, empirical, 'Functional sufficiency of neurorights legislative frameworks').


/* ==========================================================================
   7. INTEGRATION HOOKS
   ========================================================================== */

narrative_ontology:interval(neurotechnology_oversight, 0, 10).

/* ==========================================================================
   8. TEMPORAL MEASUREMENTS (LIFECYCLE DRIFT DATA)
   ========================================================================== */

% Theater ratio over time
narrative_ontology:measurement(neuro_tr_t0, neurotechnology_oversight, theater_ratio, 0, 0.52).
narrative_ontology:measurement(neuro_tr_t3, neurotechnology_oversight, theater_ratio, 3, 0.6).
narrative_ontology:measurement(neuro_tr_t6, neurotechnology_oversight, theater_ratio, 6, 0.66).
narrative_ontology:measurement(neuro_tr_t10, neurotechnology_oversight, theater_ratio, 10, 0.68).

% Extraction over time
narrative_ontology:measurement(neuro_be_t0, neurotechnology_oversight, base_extractiveness, 0, 0.38).
narrative_ontology:measurement(neuro_be_t3, neurotechnology_oversight, base_extractiveness, 3, 0.48).
narrative_ontology:measurement(neuro_be_t6, neurotechnology_oversight, base_extractiveness, 6, 0.56).
narrative_ontology:measurement(neuro_be_t10, neurotechnology_oversight, base_extractiveness, 10, 0.58).


/* ==========================================================================
   9. BOLTZMANN & NETWORK DATA
   ========================================================================== */

narrative_ontology:coordination_type(neurotechnology_oversight, enforcement_mechanism).
narrative_ontology:affects_constraint(neurotechnology_oversight, algorithmic_transparency_medical_devices).
narrative_ontology:affects_constraint(neurotechnology_oversight, patient_data_ownership_rights).
narrative_ontology:affects_constraint(neurotechnology_oversight, regulatory_capture_biomedical_policy).

% DUAL FORMULATION NOTE:
% Neurotechnology oversight decomposes into at least three structurally distinct constraints: (1) algorithmic transparency (ε ≈ 0.35, primarily engineering/verification problem), (2) patient data ownership (ε ≈ 0.65, primarily commercial extraction), (3) regulatory capture (ε ≈ 0.50, institutional/political). Each has different base extraction rates, different beneficiary/victim relationships, and different resolution pathways. This story captures the oversight mechanism aggregated across these constraints; linked stories address each component separately per ε-invariance principle.

/* ==========================================================================
   10. DIRECTIONALITY OVERRIDES (v6.0, OPTIONAL)
   ========================================================================== */

constraint_indexing:directionality_override(neurotechnology_oversight, institutional, 0.45).

/* ==========================================================================
   END OF CONSTRAINT STORY
   ========================================================================== */
